Supporting U.S. role in saving children's lives and protecting health in low-income countries through Gavi vaccines.
This bill affirms U.S. support for Gavi, the Vaccine Alliance, to purchase vaccines for low-income countries. Gavi aims to introduce and scale up new and routine immunizations, improve sustainability, and strengthen health systems. The U.S. has contributed to Gavi since 2000, supporting immunization of over 1.1 billion children and averting 18.8 million deaths. Gavi has reduced vaccine prices by 24% and increased manufacturers from 5 to 19. The U.S. encourages continued investment in Gavi for the 2026-2030 period, focusing on malaria vaccines and other initiatives.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.